Amy | Sales manager
Phone:+86 19142414382(whatsapp)
Email:shengzhikai3@shengzhikai.com
Address: 903, block B, Fortune Plaza, Luyang District, Hefei City, Anhui Province
Retatrutide is an investigational single molecule that activates the body's receptors for three hormones - glucagon, glucose-dependent insulinotropic polypeptide (GIP), and glucagon-like peptide-1 (GLP-1), and is being studied for the treatment of obesity.
| Product Name | Retatrutide |
| CAS NO. | 2381089-83-2 |
| Other name | LY3437943 GIPR/GLP-1R |
| Appearance | White freeze dry Powder |
| Purity | 99.88%min. HPLC |
| Application | Drug peptides |
| Shelf Life | 24Months |
| Storage | Store at a temperature of 2-8 oC, protected from light |
How is Retatrutide different from Semaglutide and Trizepatide ?
Mechanism:
1. Semaglutide work as (GLP-1) hormone agonist.
2. Tirezepatide work as (GLP-1 & GIP ) hormone agonist.
3. Retatrutide work as (GLP-1 & GIP & Glucagon) hormones agonist.
Weight loss in trials:
1. Semaglutide led to a 6-12% reduction in body weight in 28 weeks
2. Tirezepatide led to a 15-20% reduction in body weight in 72 weeks
3. Retatrutide led to a 25% reduction in body weight in 48 weeks

